These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

775 related items for PubMed ID: 31236693

  • 1. Validation of National Cardiovascular Data Registry risk models for mortality, bleeding and acute kidney injury in interventional cardiology at a German Heart Center.
    Wolff G, Lin Y, Quade J, Bader S, Kosejian L, Brockmeyer M, Karathanos A, Parco C, Krieger T, Heinen Y, Perings S, Albert A, Icks A, Kelm M, Schulze V.
    Clin Res Cardiol; 2020 Feb; 109(2):235-245. PubMed ID: 31236693
    [Abstract] [Full Text] [Related]

  • 2. Risk of contrast-induced acute kidney injury in ST-elevation myocardial infarction patients undergoing multi-vessel intervention-meta-analysis of randomized trials and risk prediction modeling study using observational data.
    Chatterjee S, Kundu A, Mukherjee D, Sardar P, Mehran R, Bashir R, Giri J, Abbott JD.
    Catheter Cardiovasc Interv; 2017 Aug 01; 90(2):205-212. PubMed ID: 28112470
    [Abstract] [Full Text] [Related]

  • 3. The investigation of TIMI risk index for prediction of contrast-induced acute kidney injury in patients with ST elevation myocardial infarction.
    Çınar T, Karabağ Y, Ozan Tanık V, Çağdaş M, Rencüzoğulları İ, Öz A.
    Acta Cardiol; 2020 Feb 01; 75(1):77-84. PubMed ID: 30678606
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of the preventive efficacy of rosuvastatin versus atorvastatin in post-contrast acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Dai Y, Huang J, Zeng L, Huang Z, Duan C, Shao S, Chen H, Xue L, Chen J, Tan N, He P, Liu Y, Yu D.
    Biomed Pharmacother; 2020 Aug 01; 128():110336. PubMed ID: 32521452
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Impact of contrast-induced acute kidney injury on outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Kume K, Yasuoka Y, Adachi H, Noda Y, Hattori S, Araki R, Kohama Y, Imanaka T, Matsutera R, Kosugi M, Sasaki T.
    Cardiovasc Revasc Med; 2013 Aug 01; 14(5):253-7. PubMed ID: 23993293
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Correlation and prognostic role of neutrophil to lymphocyte ratio and SYNTAX score in patients with acute myocardial infarction treated with percutaneous coronary intervention: A six-year experience.
    Zuin M, Rigatelli G, Picariello C, dell'Avvocata F, Marcantoni L, Pastore G, Carraro M, Nanjundappa A, Faggian G, Roncon L.
    Cardiovasc Revasc Med; 2017 Dec 01; 18(8):565-571. PubMed ID: 28529092
    [Abstract] [Full Text] [Related]

  • 11. Outcomes in patients with acute coronary syndrome in a referral hospital in sub-Saharan Africa.
    Varwani MH, Jeilan M, Ngunga M, Barasa A.
    Cardiovasc J Afr; 2017 Dec 01; 30(1):29-33. PubMed ID: 30534849
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of neutrophil gelatinase-associated lipocalin and cystatin C as biomarkers of acute kidney injury after ST-segment elevation myocardial infarction treated by percutaneous coronary intervention.
    Nguyen LS, Spagnoli V, Kerneis M, Hauguel-Moreau M, Barthélémy O, Collet JP, Montalescot G, Silvain J.
    Arch Cardiovasc Dis; 2019 Mar 01; 112(3):180-186. PubMed ID: 30639197
    [Abstract] [Full Text] [Related]

  • 13. Short and Midterm Outcomes in Patients With Acute Myocardial Infarction: Results of the Nationwide TURKMI Registry.
    Kilickap M, Erol MK, Kayikcioglu M, Kocayigit I, Gitmez M, Can V, Besli F, Sabanoglu C, Ungan I, Genc A, Karatas M, Dursun I, Oztekin GMY, Candemir A, Celik Y, Yanik A, Halac AHY, Akturk IF, Sunbul M, Sarikaya R, Ari H, Yalcın AA, Günes H.
    Angiology; 2021 Apr 01; 72(4):339-347. PubMed ID: 33233917
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Establishment and validation of a risk model for prediction of in-hospital mortality in patients with acute ST-elevation myocardial infarction after primary PCI.
    Gao N, Qi X, Dang Y, Li Y, Wang G, Liu X, Zhu N, Fu J.
    BMC Cardiovasc Disord; 2020 Dec 09; 20(1):513. PubMed ID: 33297955
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Twelve-month clinical outcomes of acute non-ST versus ST-segment elevation myocardial infarction patients with reduced preprocedural thrombolysis in myocardial infarction flow undergoing percutaneous coronary intervention.
    Baek JY, Kang TS, Rha SW, Choi BG, Park SH, Jeong MH.
    Coron Artery Dis; 2018 Aug 09; 29(5):416-422. PubMed ID: 29708887
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.